Health officials are concerned that the presence of both viruses could put more people in the hospital and strain Washington’s health care system.
Sceptics aren’t all the same
Kara Gavin, University of Michigan Health Lab Poll shows only 29% of adults who take five or more prescription drugs have had a comprehensive medication review. Two-thirds of older adults rely on at least two prescription drugs, and more than…
The way we train our immune systems now to respond to SARS-CoV-2 could impact how well our bodies can respond to future coronaviruses.
Anti-vaccine conspiracy theories and misinformation campaigns have gained traction. The history of these movements help explain why they are often effective.
A vaccine is vital in fighting the virus, but it won’t be a quick pass back to our old lives.
If you look at all the steps needed for a coronavirus vaccine to be scientifically validated and cleared for public use. tt’s a long shot in 38 days.
Data and safety monitoring boards (DSMBs) are supposed to make sure the medicine is safe and it works and they can halt a clinical trial or fast-track it.
The flu can be very serious for people who are 65 years and older. A flu shot is your best protection from getting and spreading the virus.
A great deal of uncertainty remains about what happened to the unnamed patient, to the frustration of those avidly following the progress of vaccine testing.
We can’t predict exactly what will happen when the flu arrives while COVID-19 still here; That makes it even more important to get a flu shot.
Armed with 9 million free flu shots from the CDC and $140 million in additional flu vaccination funding, states are taking extraordinary steps to get people inoculated.
The public is deeply skeptical about any coronavirus vaccine approved before the November election–only 42% would be willing to get a vaccine in that scenario.
The pause in the trials doesn’t necessarily mean it’s not safe. Rather, it indicates the testing is progressing as it should, with due consideration of safety.
Instead of treating COVID-19 patients with plasma, hospitals want to conduct a gold-standard clinical trial to determine whether the treatment actually works.